Praxis Investment Management Inc. Acquires 2,337 Shares of Lam Research Corporation $LRCX

Praxis Investment Management Inc. raised its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 8.1% in the first quarter, Holdings Channel.com reports. The firm owned 31,227 shares of the semiconductor company’s stock after buying an additional 2,337 shares during the period. Praxis Investment Management Inc.’s holdings in Lam Research were worth $6,672,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research in the fourth quarter valued at approximately $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the third quarter valued at approximately $26,000. Bayban bought a new stake in Lam Research during the fourth quarter worth $26,000. Vermillion Wealth Management Inc. bought a new stake in Lam Research during the first quarter worth $26,000. Finally, Triumph Capital Management purchased a new stake in Lam Research in the 3rd quarter valued at $27,000. 84.61% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 6,010 shares of Lam Research stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the completion of the sale, the insider directly owned 53,205 shares in the company, valued at $13,762,005.30. This trade represents a 10.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 86,339 shares of company stock valued at $27,680,267 in the last three months. Company insiders own 0.31% of the company’s stock.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $351.41 on Friday. Lam Research Corporation has a 1 year low of $90.93 and a 1 year high of $438.50. The company has a market capitalization of $439.46 billion, a PE ratio of 66.30, a price-to-earnings-growth ratio of 2.10 and a beta of 1.80. The business has a fifty day moving average price of $326.35 and a two-hundred day moving average price of $257.36. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. The company had revenue of $5.84 billion for the quarter, compared to analysts’ expectations of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The business’s revenue for the quarter was up 23.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Analysts forecast that Lam Research Corporation will post 5.68 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th will be paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Wednesday, June 17th. Lam Research’s payout ratio is presently 19.62%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on LRCX shares. The Goldman Sachs Group restated a “buy” rating and set a $290.00 price objective on shares of Lam Research in a research note on Thursday, April 23rd. TD Cowen increased their target price on shares of Lam Research from $290.00 to $340.00 and gave the company a “buy” rating in a report on Thursday, April 23rd. Morgan Stanley raised shares of Lam Research from an “underweight” rating to an “overweight” rating and raised their price target for the company from $293.00 to $331.00 in a research report on Monday, May 18th. New Street Research boosted their price target on shares of Lam Research from $235.00 to $280.00 and gave the stock a “neutral” rating in a report on Monday, April 27th. Finally, UBS Group reaffirmed a “buy” rating and issued a $375.00 price objective (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. Twenty-eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $345.39.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.